D.E. Shaw & Co’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-30,635
| Closed | -$148K | – | 2934 |
|
|
2020
Q1 | $148K | Buy |
+30,635
| New | +$148K | ﹤0.01% | 2508 |
|
|
2019
Q1 | – | Sell |
-17,675
| Closed | -$168K | – | 2804 |
|
|
2018
Q4 | $168K | Sell |
17,675
-85,939
| -83% | -$817K | ﹤0.01% | 2411 |
|
|
2018
Q3 | $1.72M | Sell |
103,614
-91,678
| -47% | -$1.52M | ﹤0.01% | 1591 |
|
|
2018
Q2 | $3.13M | Sell |
195,292
-55,129
| -22% | -$885K | ﹤0.01% | 1388 |
|
|
2018
Q1 | $3.83M | Buy |
250,421
+57,588
| +30% | +$881K | 0.01% | 1187 |
|
|
2017
Q4 | $3.01M | Buy |
192,833
+105,539
| +121% | +$1.65M | ﹤0.01% | 1311 |
|
|
2017
Q3 | $969K | Sell |
87,294
-14,990
| -15% | -$166K | ﹤0.01% | 1802 |
|
|
2017
Q2 | $941K | Buy |
102,284
+88,782
| +658% | +$817K | ﹤0.01% | 1756 |
|
|
2017
Q1 | $115K | Sell |
13,502
-17,755
| -57% | -$151K | ﹤0.01% | 2336 |
|
|
2016
Q4 | $334K | Buy |
31,257
+2,611
| +9% | +$27.9K | ﹤0.01% | 2191 |
|
|
2016
Q3 | $310K | Sell |
28,646
-4,794
| -14% | -$51.9K | ﹤0.01% | 2193 |
|
|
2016
Q2 | $226K | Sell |
33,440
-16,157
| -33% | -$109K | ﹤0.01% | 2348 |
|
|
2016
Q1 | $231K | Sell |
49,597
-3,432
| -6% | -$16K | ﹤0.01% | 2345 |
|
|
2015
Q4 | $335K | Buy |
+53,029
| New | +$335K | ﹤0.01% | 2234 |
|
|
2015
Q3 | – | Sell |
-12,342
| Closed | -$145K | – | 2789 |
|
|
2015
Q2 | $145K | Buy |
+12,342
| New | +$145K | ﹤0.01% | 2511 |
|
|
2014
Q1 | – | Sell |
-22,002
| Closed | -$431K | – | 2660 |
|
|
2013
Q4 | $431K | Sell |
22,002
-9,532
| -30% | -$187K | ﹤0.01% | 2000 |
|
|
2013
Q3 | $1.43M | Sell |
31,534
-45,644
| -59% | -$2.07M | ﹤0.01% | 1403 |
|
|
2013
Q2 | $1.84M | Buy |
+77,178
| New | +$1.84M | ﹤0.01% | 1242 |
|